Raised H.B. No. 5366
Session Year 2020


To: (1) Cap aggregate monthly cost-sharing for prescription drugs covered under certain individual and group health insurance policies; (2) cap the cost of generic drugs in this state; (3) require the Commissioner of Consumer Protection to submit a request to the federal Secretary of Health and Human Services to implement a Canadian prescription drug reimportation program in this state and, if the secretary approves such request, implement such program in this state; (4) require pharmaceutical manufacturers to send notice to the Insurance Commissioner regarding "pay-for-delay" agreements, and require health carriers and pharmacy benefits managers to reduce the cost of brand name prescription drugs that are the subject of such agreements; (5) establish a Critical Drug Shortage Review Board; and (6) limit the circumstances in which a health carrier may remove a prescription drug from a drug formulary or list of covered drugs, or move a prescription drug to a different cost-sharing tier, during a plan year.

Introduced by:
Insurance and Real Estate Committee

 New today  2-4 days old  5 days & older
   Text of Bill
 Raised Bill  [doc]

Co-sponsors for Amendment LCO:

Bill History

 Date Action Taken
 3/11/2020(LCO)Filed with Legislative Commissioners' Office
 3/10/2020(INS)Joint Favorable Substitute
 2/28/2020Public Hearing 03/03
 2/27/2020Referred to Joint Committee on Insurance and Real Estate

Co-sponsors of HB-5366

Sen. Saud Anwar, 3rd Dist.

NOTE: Please direct all inquiries regarding the status of bills to the Office of the House Clerk and/or Senate Clerks' Office.